The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis
Open accessAbstract
OBJECTIVES: To quantify the influence of physicians' experiences of adverse events in patients with atrial fibrillation who were taking warfarin. DESIGN: Population based, matched pair before and after analysis. SETTING: Database study in Ontario, Canada. PARTICIPANTS: The physicians of patients with atrial fibrillation admitted to hospital for adverse events (major haemorrhage while taking warfarin and thromboembolic strokes while not taking warfarin). Pairs of other patients with atrial fibrillation treated by the same physicians were selected. MAIN OUTCOME MEASURES: Odds of receiving warfarin by matched pairs of a given physician's patients (one treated after and one treated before the event) were compared, with adjustment for stroke and bleeding risk factors that might also influence warfarin use. The odds of prescriptions for angiotensin converting enzyme (ACE) inhibitor before and after the event was assessed as a neutral control. RESULTS: For the 530 physicians who had a patient with an adverse bleeding event (exposure) and who treated other patients with atrial fibrillation during the 90 days before and the 90 days after the exposure, the odds of prescribing warfarin was 21% lower for patients after the exposure (adjusted odds ratio 0.79, 95% confidence interval 0.62 to 1.00). Greater reductions in warfarin prescribing were found in analyses with patients for whom more time had elapsed between the physician's exposure and the patient's treatment. There were no significant changes in warfarin prescribing after a physician had a patient who had a stroke while not on warfarin or in the prescribing of ACE inhibitors by physicians who had patients with either bleeding events or strokes. CONCLUSIONS: A physician's experience with bleeding events associated with warfarin can influence prescribing warfarin. Adverse events that are possibly associated with underuse of warfarin may not affect subsequent prescribing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Atrial Fibrillation: A Major Contributor to Stroke in the Elderly: The Framingham Study
Wolf, P. A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090041008 · Cited by 1,108
Evidence of self-report bias in assessing adherence to guidelines
Adams, A., Soumerai, S., Lomas, J., & Ross-Degnan, D. (1999) · International Journal for Quality in Health Care · doi:10.1093/intqhc/11.3.187 · Cited by 679
Self-citationCost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
Stewart, S., Murphy, N., Walker, A., McGuire, A., & McMurray, J. J. V. (2004) · Heart · doi:10.1136/hrt.2002.008748 · Cited by 590
Soumerai, S. B., McLaughlin, T. J., Gurwitz, J. H., Guadagnoli, E., Hauptman, P. J., Borbas, C., Morris, N., McLaughlin, B., Gao, X., Willison, D. J., et al. (1998) · JAMA · doi:10.1001/jama.279.17.1358 · Cited by 479
Self-citation
Cited by
Gladstone, D. J., Bui, E., Fang, J., Laupacis, A., Lindsay, M. P., Tu, J. V., Silver, F. L., & Kapral, M. K. (2009) · Stroke · doi:10.1161/strokeaha.108.516344 · Cited by 402
Self-citationCaraco, Y., Blotnick, S., & Muszkat, M. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100316 · Cited by 360
Learning from Big Health Care Data
Schneeweiss, S. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1401111 · Cited by 320
Clinical pharmacology in the geriatric patient
Hilmer, S. N., McLachlan, A. J., & Le Couteur, D. G. (2007) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00473.x · Cited by 296
The Increasing Prevalence of Atrial Fibrillation among Hemodialysis Patients
Winkelmayer, W. C., Patrick, A. R., Liu, J., Brookhart, M. A., & Setoguchi, S. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050459 · Cited by 275
Metadata
- Authors
- Choudhry, N. K., Anderson, G. M., Laupacis, A., Ross-Degnan, D., Normand, S.-L. T., & Soumerai, S. B.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2006-01-10
- Volume
- 332
- Issue
- 7534
- Pages
- 141-145
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2000789055
- Cited by
- 186
- References
- 5
- FWCI
- 10.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis. https://app.cochat.ai/papers/10.1136/bmj.38698.709572.55
- The paper
- Choudhry, N. K., Anderson, G. M., Laupacis, A., Ross-Degnan, D., Normand, S.-L. T., & Soumerai, S. B. (2006). Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis. BMJ. https://doi.org/10.1136/bmj.38698.709572.55
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.